Funding Rounds
Vector BioPharma

Vector BioPharma Series A (2022, $30M)

Vector BioPharma

Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $30.00M

Raised Date: 2022-01-01